Cookies

Like most websites The Pathologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Inside the Lab Precision medicine, Oncology, Biochemistry and molecular biology, Clinical care

Precision Oncology Flourishes In-House

sponsored by Thermo Fisher Scientific

The UK’s 100,000 Genomes Project reached its goal of sequencing 100,000 entire patient genomes in December 2018. Capitalizing on this success, January 2019 saw the establishment of a new, nationally commissioned Genomic Medicine Service that harnesses seven Genomic Laboratory Hubs around the country. The goal is to standardize the criteria for whole genome sequencing and targeted panel tests, simplifying patient pathways and reducing social inequalities – but is this democratization of genetic testing the best option for all institutions? We spoke to Tanya Ahmad, Consultant Medical Oncologist in London, to discover her personal outlook on in-house testing versus centralization.

Read the full article now

Log in or register to read this article in full and gain access to The Pathologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Tanya Ahmad

Consultant Medical Oncologist in London, UK.

Register to The Pathologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Pathologist magazine

Register